We are live on ! Find out more
Rafferty Asset Management

Rafferty Asset Management Portfolio holdings

AUM $24.6B
1-Year Est. Return 47.06%
This Fund
S&P 500
This Quarter Est. Return
+3.34%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$5.69B
AUM Growth
-$527M
Cap. Flow
-$681M
Cap. Flow %
-11.98%
Top 10 Hldgs %
44.35%
Holding
882
New
93
Increased
308
Reduced
393
Closed
87

Sector Composition

Rank Sector Weight
1 Financials 13.89%
2 Technology 9.88%
3 Healthcare 7.2%
4 Energy 6.87%
5 Real Estate 3.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STI
151
DELISTED
SunTrust Banks, Inc.
STI
$5.25M 0.09%
83,592
-14,319
-15% -$900K
PTLA
152
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$5.21M 0.09%
192,003
+37,696
+24% +$1.18M
ABBV icon
153
AbbVie
ABBV
$455B
$5.2M 0.09%
71,549
+4,815
+7% +$378K
DINO icon
154
HF Sinclair
DINO
$16.3B
$5.2M 0.09%
112,316
+64,582
+135% +$2.89M
SAGE
155
DELISTED
Sage Therapeutics
SAGE
$5.2M 0.09%
28,372
-4,492
-14% -$766K
ONCE
156
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$5.18M 0.09%
50,603
+22,573
+81% +$2.44M
MDCO
157
DELISTED
Medicines Co
MDCO
$5.18M 0.09%
+141,979
New +$4.63M
BPMC
158
DELISTED
Blueprint Medicines
BPMC
$5.14M 0.09%
54,512
+18,182
+50% +$1.5M
EBS icon
159
Emergent Biosolutions
EBS
$381M
$5.14M 0.09%
106,398
+26,947
+34% +$1.29M
ALNY icon
160
Alnylam Pharmaceuticals
ALNY
$37.3B
$5.14M 0.09%
70,777
+11,052
+19% +$848K
IONS icon
161
Ionis Pharmaceuticals
IONS
$9.26B
$5.13M 0.09%
79,864
+9,477
+13% +$670K
ALKS icon
162
Alkermes
ALKS
$8.81B
$5.1M 0.09%
226,147
+94,911
+72% +$2.6M
SGEN
163
DELISTED
Seagen Inc. Common Stock
SGEN
$5.01M 0.09%
72,383
+530
+0.7% +$37.1K
MUR icon
164
Murphy Oil
MUR
$5.39B
$4.98M 0.09%
202,025
+103,550
+105% +$2.74M
NBIX icon
165
Neurocrine Biosciences
NBIX
$17.8B
$4.97M 0.09%
58,919
-5,611
-9% -$461K
VTR icon
166
Ventas
VTR
$48.6B
$4.97M 0.09%
72,683
-9,926
-12% -$633K
DLR icon
167
Digital Realty Trust
DLR
$72.4B
$4.95M 0.09%
42,038
-5,676
-12% -$676K
ICPT
168
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$4.95M 0.09%
62,176
+13,041
+27% +$1.17M
UTHR icon
169
United Therapeutics
UTHR
$26.2B
$4.93M 0.09%
63,196
+17,735
+39% +$1.66M
PDCE
170
DELISTED
PDC Energy, Inc.
PDCE
$4.93M 0.09%
136,649
+65,048
+91% +$2.45M
RGNX icon
171
Regenxbio
RGNX
$620M
$4.91M 0.09%
95,640
+37,742
+65% +$1.88M
GBT
172
DELISTED
Global Blood Therapeutics, Inc.
GBT
$4.82M 0.08%
91,588
-7,561
-8% -$435K
PBF icon
173
PBF Energy
PBF
$7.43B
$4.81M 0.08%
153,541
+73,871
+93% +$2.2M
EWW icon
174
iShares MSCI Mexico ETF
EWW
$1.91B
$4.78M 0.08%
110,156
+34,226
+45% +$1.54M
WOLF icon
175
Wolfspeed
WOLF
$1.24B
$4.77M 0.08%
84,939
+5,448
+7% +$333K

Similar funds

Rafferty Asset Management's Q2 2019 Portfolio in Review

As of Q2 2019, Rafferty Asset Management held 882 positions worth $5.69B, down 8.5% from $6.22B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Rafferty Asset Management withdrew a net $681M in Q2 2019, closing 87 positions and reducing 393 holdings. Its most notable exit was State Street Energy Select Sector SPDR ETF, an estimated $266M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Rafferty Asset Management opened a new position in SLB Ltd worth $7.45M.

  • Rafferty Asset Management's largest Q2 2019 buy was SLB Ltd: 187,346 shares worth $7.45M.
  • Rafferty Asset Management added most to ExxonMobil in Q2 2019, an estimated $37.1M increase.
  • Rafferty Asset Management's biggest Q2 2019 reduction was VanEck Gold Miners ETF, cutting an estimated $187M.
  • Rafferty Asset Management fully exited State Street Energy Select Sector SPDR ETF in Q2 2019, selling an estimated $266M.
  • Rafferty Asset Management's ten largest holdings make up 44% of its $5.69B portfolio in Q2 2019.
  • Rafferty Asset Management opened 93 new positions and closed 87 in Q2 2019.
  • Rafferty Asset Management's portfolio value fell 8.5% quarter-over-quarter to $5.69B.

Based on Rafferty Asset Management's 13F filing for Q2 2019, filed 9 Aug 2019.